Anaptysbio share price today

(ANAB)

Anaptysbio share price is $13.89 & ₹1,183.40 as on 25 Dec 2024, 2.30 'hrs' IST

$13.89

▲

-0.08

(-0.57%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Anaptysbio share price in Dollar and Rupees. Guide to invest in Anaptysbio from India. Also see the sentimental analysis on Indian investors investing in Anaptysbio. Get details on the Indian mutual funds that are investing in Anaptysbio. Get Analyst recommendations and forecasts along with all the Anaptysbio's financials.

Anaptysbio share price movements

Today's Low: $13.85
Today's High: $14.59
$13.89
0.29%
Downside
Day's Volatility :5.07%
Upside
4.8%
52 Weeks Low: $13.82
52 Weeks High: $41.31
$13.89
0.5%
Downside
52 Weeks Volatility :66.54%
Upside
66.37%

Anaptysbio Returns

Period	Anaptysbio Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-57.27%	-9.0%	0.0%
6 Months	-43.99%	-4.6%	0.0%
1 Year	-36.46%	3.0%	0.0%
3 Years	-61.95%	0.0%	-21.1%

Anaptysbio Key Statistics

in dollars & INR

Previous Close	$13.97
Open	$13.91
Today's High	$14.59
Today's Low	$13.85
Market Capitalization	$422.7M
Today's Volume	$238.4K
52 Week High	$41.3083
52 Week Low	$13.82
Revenue TTM	$57.2M
EBITDA	$-139.4M
Earnings Per Share (EPS)	$-6.05
Profit Margin	-289.75%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-161.82%

How to invest in Anaptysbio from India?

It is very easy for Indian residents to invest directly in Anaptysbio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Anaptysbio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Anaptysbio or ANAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Anaptysbio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Anaptysbio shares which would translate to 0.061 fractional shares of Anaptysbio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Anaptysbio, in just a few clicks!

Returns in Anaptysbio for Indian investors in Rupees

Investment Value

₹1,00,000

Anaptysbio investment value today

Current value as on today

₹65,779

Returns

₹34,221

(-34.22%)

Returns from Anaptysbio Stock

₹36,459 (-36.46%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Anaptysbio

21%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Anaptysbio on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 21% more investors are searching Anaptysbio in the last 30 days versus the previous period.

Global Institutional Holdings in Anaptysbio

EcoR1 Capital, LLC
25.62%
FMR Inc
10.88%
BlackRock Inc
5.82%
Vanguard Group Inc
5.59%
TANG CAPITAL MANAGEMENT LLC
4.37%
Boxer Capital LLC
4.27%

Analyst Recommendation on Anaptysbio

Buy

75%Buy

25%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Anaptysbio(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Anaptysbio

What analysts predicted

Upside of 157.02%

Current:

$13.89

Target:

$35.70

Insights on Anaptysbio

Price Movement
In the last 7 days, ANAB stock has moved down by -7.4%
Increasing Revenue
Revenue is up for the last 3 quarters, 7.17M → 30.01M (in $), with an average increase of 49.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -46.66M → -32.85M (in $), with an average increase of 42.0% per quarter
ANAB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 62.5%
ANAB vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 87.7%
Price to Sales
ForANAB every $1 of sales, investors are willing to pay $6.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Anaptysbio Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$5.0M	↓ 50.0%
Net Income	$-61.7M	↑ 105.04%
Net Profit Margin	-1.2K%	↓ 932.42%

	FY19	Y/Y Change
Revenue	$8.0M	↑ 60.0%
Net Income	$-97.3M	↑ 57.87%
Net Profit Margin	-1.2K%	↑ 16.42%

	FY20	Y/Y Change
Revenue	$75.0M	↑ 837.5%
Net Income	$-19.9M	↓ 79.53%
Net Profit Margin	-26.56%	↑ 1190.14%

	FY21	Y/Y Change
Revenue	$63.2M	↓ 15.77%
Net Income	$-57.2M	↑ 187.11%
Net Profit Margin	-90.53%	↓ 63.97%

	FY22	Y/Y Change
Revenue	$10.3M	↓ 83.72%
Net Income	$-128.7M	↑ 125.07%
Net Profit Margin	-1.3K%	↓ 1160.8%

	FY23	Y/Y Change
Revenue	$17.2M	↑ 66.78%
Net Income	$-163.6M	↑ 27.11%
Net Profit Margin	-953.66%	↑ 297.67%

	Q2 FY23	Q/Q Change
Revenue	$3.5M	↑ 151.82%
Net Income	$-39.8M	↓ 17.75%
Net Profit Margin	-1.2K%	↑ 2374.25%

	Q3 FY23	Q/Q Change
Revenue	$3.3M	↓ 4.1%
Net Income	$-37.3M	↓ 6.37%
Net Profit Margin	-1.1K%	↑ 27.18%

	Q4 FY23	Q/Q Change
Revenue	$9.0M	↑ 171.4%
Net Income	$-42.2M	↑ 13.14%
Net Profit Margin	-468.75%	↑ 655.66%

	Q1 FY24	Q/Q Change
Revenue	$7.2M	↓ 20.28%
Net Income	$-43.9M	↑ 4.09%
Net Profit Margin	-612.01%	↓ 143.26%

	Q2 FY24	Q/Q Change
Revenue	$11.0M	↑ 52.82%
Net Income	$-46.7M	↑ 6.2%
Net Profit Margin	-425.3%	↑ 186.71%

	Q3 FY24	Q/Q Change
Revenue	$30.0M	↑ 173.6%
Net Income	$-32.9M	↓ 29.59%
Net Profit Margin	-109.44%	↑ 315.86%

	FY18	Y/Y Change
Profit	$5.0M	↓ 50.0%

	FY19	Y/Y Change
Profit	$-91.3M	↓ 1926.76%

	FY20	Y/Y Change
Profit	$-5.0M	↓ 94.5%

	FY21	Y/Y Change
Profit	$-35.3M	↑ 602.91%

	FY22	Y/Y Change
Profit	$8.0M	↓ 122.51%

	FY23	Y/Y Change
Profit	$14.8M	↑ 85.88%

	Q2 FY23	Q/Q Change
Profit	$2.9M	↑ 267.86%

	Q3 FY23	Q/Q Change
Profit	$2.7M	↓ 5.12%

	Q4 FY23	Q/Q Change
Profit	$8.4M	↑ 208.18%

	Q1 FY24	Q/Q Change
Profit	$6.6M	↓ 21.75%

	Q2 FY24	Q/Q Change
Profit	$10.4M	↑ 57.83%

	Q3 FY24	Q/Q Change
Profit	$29.4M	↑ 183.55%

	FY18	Y/Y Change
Operating Cash Flow	$-48.5M	↑ 149.54%
Investing Cash Flow	$-142.5M	↓ 41.39%
Financing Cash Flow	$223.4M	↓ 23.62%

	FY19	Y/Y Change
Operating Cash Flow	$-69.5M	↑ 43.32%
Investing Cash Flow	$131.4M	↓ 192.26%
Financing Cash Flow	$-4.5M	↓ 102.01%

	FY20	Y/Y Change
Operating Cash Flow	$-14.2M	↓ 79.64%
Investing Cash Flow	$94.5M	↓ 28.12%
Financing Cash Flow	$-879.0K	↓ 80.44%

	FY21	Y/Y Change
Operating Cash Flow	$-45.9M	↑ 224.36%
Investing Cash Flow	$38.8M	↓ 58.89%
Financing Cash Flow	$252.3M	↓ 28802.84%

	FY22	Y/Y Change
Operating Cash Flow	$-73.6M	↑ 60.26%
Investing Cash Flow	$-394.8M	↓ 1116.72%
Financing Cash Flow	$44.0M	↓ 82.55%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-25.4M	↑ 3.42%
Investing Cash Flow	$-20.5M	↓ 123.95%
Financing Cash Flow	$-13.5M	↓ 64.09%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-36.5M	↑ 43.55%
Investing Cash Flow	$30.6M	↓ 249.77%
Financing Cash Flow	$-3.1M	↓ 77.23%

Anaptysbio Technicals Summary

Sell

Neutral

Buy

Anaptysbio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Anaptysbio Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Anaptysbio Inc	-44.99%	-43.99%	-36.46%	-61.95%	-12.92%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Anaptysbio Inc	NA	NA	0.0	-6.18	-1.62	-0.18	NA	2.77
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Anaptysbio Inc	Buy	$422.7M	-12.92%	NA	-289.75%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Anaptysbio

founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio’s proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c

Organization	Anaptysbio
Employees	117
CEO	Mr. Daniel R. Faga
Industry	Health Technology

Management People of Anaptysbio

Name	Title
Mr. Daniel R. Faga	President, CEO & Director
Mr. Eric J. Loumeau	Chief Legal Officer
Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D.	Chief Medical Officer
Mr. Dennis M. Mulroy	Chief Financial Officer
Ms. Beth Mueller	Senior Vice President of Human Resources
Dr. Martin Dahl Ph.D.	Senior Vice President of Research
Mr. Benjamin Stone	Chief Business Officer
Mr. Douglas A. Rich M.B.A.	Senior Vice President of CMC
Ms. Monique Da Silva	Senior Vice President of Corporate Affairs
Ms. Priya Raina	Senior Vice President of Clinical Operations

Important FAQs about investing in Anaptysbio from India :

What is Anaptysbio share price today?

Anaptysbio share price today stands at $13.89, Open: $13.91 ; Previous Close: $13.97 ; High: $14.59 ; Low: $13.85 ; 52 Week High: $41.31 ; 52 Week Low: $13.82. The stock opens at $13.91, after a previous close of $13.97. The stock reached a daily high of $14.59 and a low of $13.85, with a 52-week high of $41.31 and a 52-week low of $13.82.

Can Indians buy Anaptysbio shares?

Yes, Indians can invest in the Anaptysbio (ANAB) from India.

With INDmoney, you can buy Anaptysbio at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Anaptysbio at zero transaction cost.

How can I buy Anaptysbio shares from India?

It is very easy to buy Anaptysbio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Anaptysbio be purchased?

Yes, you can buy fractional shares of Anaptysbio with INDmoney app.

What are the documents required to start investing in Anaptysbio stocks?

To start investing in Anaptysbio, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.